Citadel Advisors’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6K | Buy |
+11,599
| New | +$26.6K | ﹤0.01% | 5602 |
|
|
2024
Q2 | – | Sell |
-1,221
| Closed | -$6.31K | – | 6704 |
|
|
2024
Q1 | $6.31K | Buy |
+1,221
| New | +$6.31K | ﹤0.01% | 5737 |
|
|
2023
Q1 | – | Sell |
-1,746
| Closed | -$51.9K | – | 6490 |
|
|
2022
Q4 | $51.9K | Buy |
+1,746
| New | +$51.9K | ﹤0.01% | 5273 |
|
|
2022
Q3 | – | Sell |
-238
| Closed | -$28K | – | 6613 |
|
|
2022
Q2 | $28K | Sell |
238
-184
| -44% | -$21.6K | ﹤0.01% | 5652 |
|
|
2022
Q1 | $70K | Buy |
+422
| New | +$70K | ﹤0.01% | 5796 |
|
|
2021
Q4 | – | Sell |
-181
| Closed | -$40K | – | 7103 |
|
|
2021
Q3 | $40K | Buy |
+181
| New | +$40K | ﹤0.01% | 6174 |
|
|
2021
Q2 | – | Sell |
-293
| Closed | -$111K | – | 7007 |
|
|
2021
Q1 | $111K | Buy |
+293
| New | +$111K | ﹤0.01% | 5799 |
|
|
2017
Q2 | – | Sell |
-306
| Closed | -$177K | – | 4104 |
|
|
2017
Q1 | $177K | Buy |
+306
| New | +$177K | ﹤0.01% | 3223 |
|